The activation of the JAK/STAT3 pathway, reported to play an important role in multiple oncogenic processes, including tumour proliferation, differentiation, angiogenesis and survival, has a significant impact on the survival of ovarian cancer patients [13,14]. This evidence concerns the gene STAT3 and neoplasm.